Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15

Experimental Immunochemistry

Postgraduate Medical Journal · 1962 · 1.5K citations · Full text

Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H

Matthew C. Pickering, H. Terence Cook, Joanna Warren et al. · Nature Genetics · 2002 · 506 citations

Medicine, Immunology, Pathology +17

Genetic studies into inherited and sporadic hemolytic uremic syndrome

Paul Warwicker, Timothy H.J. Goodship, Rosemary L. Donne et al. · Kidney International · 1998 · 493 citations

Life Sciences, Genetics, Molecular Genetics +12

Heterozygous and Homozygous Factor H Deficiencies Associated with Hemolytic Uremic Syndrome or Membranoproliferative Glomerulonephritis

Marie‐Agnès Dragon‐Durey, Véronique Frémeaux‐Bacchi, Chantal Loirat et al. · Journal of the American Society of Nephrology · 2004 · 352 citations

Medicine, Genetics, Nephrology +17

Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome

Tamara Manuelian, Jens Hellwage, Seppo Meri et al. · Journal of Clinical Investigation · 2003 · 342 citations · Full text

Medicine, Genetics, Molecular Genetics +15